Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1) > Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1):69-75

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014


eTOC

 

REVIEWS  


Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1):69-75

language: English

Vitiligo: current medical and scientific understanding

Boissy R. E. 1, Nordlund J. J. 2

1 Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA;
2 Department of Dermatology, Boonshoft School of Medicine, Wright State University Dayton, Ohio and Group Health Associates
Cincinnati, OH, USA


PDF  


Vitiligo is a relatively common acquired skin depigmentary disease with a complex presentation, therapy, and etiology. Both the prognosis and therapeutic response for patients with vitiligo is unpredictable. Multiple current therapies exist however the efficacy of these are not optimal. The cause of vitiligo appears to be a combination of genetic effects in both the immune system and the melanocyte itself with a precipitating factor instigating their interaction and resulting in the melanocyte destruction. Headway is being made in understanding the etiology of vitiligo that should culminate in new and improved therapies.

top of page

Publication History

Cite this article as

Corresponding author e-mail

boissyre@ucmail.uc.edu